More on DOSEF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.25 |
|
|||
| Open | $0.25 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.25 | ||||
| Day Low | $0.25 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 184 | ||||
- Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category
- Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot
- THE SIGNAL ARCHITECTURE: 5 Stocks Calibrating the 2026 Infrastructure Cycle
- Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors
- 5 Stocks Sitting on the Right Side of the Biggest Repricing in a Generation
- 2026 Asset Growth: Why Federal Compliance Is the New Metric
- THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
- Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors
- Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
- The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel
Entities mentioned with DOSEF
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Vanguard | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
